Dear colleagues,
Effective age regression interventions hold the potential to not only alleviate but also prevent diseases associated with aging. This groundbreaking assertion has garnered the endorsement of the majority within the scientific community who increasingly view aging not as a disease per se, but as the primary catalyst/cause for nearly all age-related diseases. Diseases caused by aging represent a staggering 85% of all diseases that plague humanity. The pharmaceutical industry is acutely aware of this catastrophically negative, financial inevitability. Although this is recognized as an inevitability it can and is being dramatically delayed through regulatory obstruction.
Approximately 45% of the FDA's total budget comes from user fees paid by biotechs and pharmaceutical comp
